MRVI
Maravai Lifesciences Holdings Inc
NASDAQ: MRVI · HEALTHCARE · BIOTECHNOLOGY
$3.68
+5.75% today
Updated 2026-04-30
Market cap
$542.79M
P/E ratio
—
P/S ratio
2.92x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$2 – $4
Volume
1.8M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
2.0
Growth
F6.5
Quality
B2.0
Profitability
F6.7
Valuation
B3/9
Piotroski F-Score
Weak
1.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$4.60
+25.00%
12-Month target
—
—
Intrinsic (DCF)
$5.40
Margin of safety
+42.22%
0 Strong Buy5 Buy5 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 42.22% below intrinsic value
+ Debt/equity 0.15x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.95 — distress zone
- Thin margins at -70.40%
- Negative free cash flow $-24.88M
- Revenue declining -11.80% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $883.00M | $288.94M | $259.19M | $185.74M | $185.74M |
| Net income | $220.21M | $-119.03M | $-144.85M | $-130.77M | $-35.68M |
| EPS | — | — | — | — | $-0.90 |
| Free cash flow | $518.89M | $60.67M | $-22.19M | $-70.72M | $-24.88M |
| Profit margin | 24.94% | -41.19% | -55.89% | -70.41% | -70.40% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-16 | ORESHACK, KURT | Sale | 39,976 | $3.08 |
| 2026-03-16 | DOLAN, CHRISTINE | Sale | 28,661 | $3.08 |
| 2026-01-15 | ORESHACK, KURT | Sale | 31,902 | $3.69 |
Peer comparison
Smart narrative
Maravai Lifesciences Holdings Inc trades at $3.68. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.95, it sits in the distress. TTM revenue stands at $185.74M. with profit margins at -70.40%. Our DCF model estimates intrinsic value at $5.40.
Frequently asked questions
What is Maravai Lifesciences Holdings Inc's stock price?
Maravai Lifesciences Holdings Inc (MRVI) trades at $3.68.
Is Maravai Lifesciences Holdings Inc overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell). DCF value $5.40.
What is the price target of Maravai Lifesciences Holdings Inc (MRVI)?
The analyst target price is $4.60, representing +25.0% upside from the current price of $3.68.
What is the intrinsic value of Maravai Lifesciences Holdings Inc (MRVI)?
Based on our DCF model, intrinsic value is $5.40, a +42.2% margin of safety versus $3.68.
What is Maravai Lifesciences Holdings Inc's revenue?
TTM revenue is $185.74M.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
0.95 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.92x
ROE-48.60%
Beta0.43
50D MA$3.25
200D MA$3.13
Shares out0.15B
Float0.10B
Short ratio—
Avg volume1.8M
Performance
1 week-0.27%
1 month+27.78%
3 months+7.60%
YTD+13.23%
1 year—
3 years—
5 years—